New potential biomarkers for breast cancer (review of literature)

Cover Page

Cite item

Full Text

Abstract

Identification of markers that will identify the disease at an early preclinical stage, is the main goal of our research. Diagnostic marker should have the following characteristics: high sensitivity and specificity, be readily accessible for the analysis of tissues and body fluids, and above all, be determined in blood plasma. Early detection of breast cancer markers in the blood – a promising trend in science, however, is technically challenging because of the heterogeneity of the disease and the variability of blood plasma proteins. Our review is devoted to theoretical assumptions and practical results of the search of new proteomic markers of breast cancer.

About the authors

M. A. Taipov

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Author for correspondence.
Email: taipoff.m@yandex.ru
Russian Federation

N. Ye. Levchenko

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Russian Federation

K. P. Laktionov

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Russian Federation

V. Ye. Shevchenko

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36991 от  21.07.2009.